Navigation Links
Precision for Medicine Adds Regulatory Expertise To Support Next Generation Medicines
Date:5/30/2013

CHEVY CHASE, Md., May 30, 2013 /PRNewswire/ -- Precision for Medicine, Inc., ("Precision"), the specialized scientific services company formed in 2012 to support next generation medical products, today announced the appointment of three key executives, significantly increasing the breadth of its regulatory and commercialization services. The addition of these executives and their teams expands and enhances Precision's ability to support life science innovators as they work to address value, effectiveness, and patient access for next generation medicines.  

(Logo:  http://photos.prnewswire.com/prnh/20130530/PH20734LOGO )

"Developers of diagnostic technologies – particularly companion diagnostics that support a new generation of biopharmaceuticals– are looking for a specific set of services as they work to guide their products to market," said Precision co-founder, Mark P. Clein . "The leadership team we have assembled at Precision for Medicine provides a unique combination of industry experience and scientific expertise to help guide all aspects of diagnostic and product development, from strategy to regulatory affairs, and from clinical trial design to commercialization."

Judi Smith , M.S., M.T. (ASCP) has been appointed Vice President, In Vitro Diagnostics Regulatory and Quality and will lead Precision's regulatory support services for diagnostic products, including companion diagnostics for next generation biopharmaceuticals. In this role, Ms. Smith will help clients guide diagnostics products from initial development through regulatory submission, review, and approval. Ms. Smith, who is currently the president of the Association of Medical Diagnostic Manufacturers, has worked in regulatory and quality sciences and clinical development for over 30 years. During that time, she has led successful regulatory submissions for a multitude of companion diagnostic assays, in vitro diagnostic products, and biological in vitro diagnostic assays to support quality control of diagnostic products. Ms. Smith earned a Masters of Science degree from the Medical College of Pennsylvania.

Merry Lee Bain , M.S., has been appointed Vice President, Medical Devices and will lead Precision's regulatory support services for medical devices. Ms. Bain guides strategic planning and implementation of regulatory strategies for clients developing products across a broad range of disciplines and therapeutic areas. Ms. Bain is a biomedical engineer with over 25 years experience in regulatory affairs for the medical device industry. She has been consulting for 10 years and held executive leadership positions in regulatory affairs at Cook Medical. Ms. Bain earned a B.S. in engineering and a M.S. in electrical engineering from Purdue University. 

Pia Maria Gargiulo , Ph.D. has been appointed Managing Director, Companion Diagnostics Solutions. In this role, Dr. Gargiulo will lead Precision's companion diagnostics programs with a focus on introducing novel technologies, and addressing the array of regulatory, clinical, and commercial requirements necessary to bring companion diagnostics to market. Before joining Precision, Dr. Gargiulo was the Vice President of companion diagnostic partnerships at Qiagen. During her tenure at Qiagen, Dr. Gargiulo worked with biopharmaceutical companies to establish successful drug-diagnostic collaborations and co-development programs. Prior to Qiagen, Dr. Gargiulo was a Therapeutic Brand Leader and Senior Regional Scientific Leader at AstraZeneca. Dr. Gargiulo earned a Ph.D. in cytogenetics from the Feinberg School of Medicine at Northwestern University.

About Precision for Medicine
Precision for Medicine (Precision), is a specialized scientific services partner dedicated to helping life science companies develop and commercialize next generation medical products.  Precision offers a unique combination of expertise, scientific infrastructure and organizational scale to help guide products from development, through regulatory review, to market introduction and commercial success. Best-in-class teams of scientists and industry expertise and a specialized portfolio of services help clients accelerate research, enable market adoption, enhance patient outcomes and realize the full commercial potential of innovative products. The company is headquartered in Chevy Chase, MD with offices in Boston, MA, Gaithersburg MD, and Frederick, MD.  For more information about Precision, visit www.precisionformedicine.com.


'/>"/>
SOURCE Precision for Medicine, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. U.K. Clinic Anticipating New Era of Radiotherapy Speed and Precision with Elektas New Versa HD System
2. Emerging Precision Medicine Powerhouse Changes Name to Increase Visibility and Overall Awesomeness
3. Precision Optics Corporation Announces Reciept Of $660,000 Purchase Order For Custom-Designed Endoscopes
4. Precision Health Economics Adds Executive Sales And Marketing Leader
5. TechPrecision Corporation Receives Nuclear Order for $860,000
6. Precision Optics Corporation, Inc. Operating Results for Six Months Ended December 31, 2012 and Recent Operating Activities
7. A New Era of Vision Correction Arrives: Breakthrough Computer Guided Laser Cataract Surgery, Finally Offers Patients Unprecedented Precision
8. Personna Industrial Previews a New Line of Precision Blades at MD&M West
9. PrecisionMD Launches NEW Anti-Redness Product - DermaChromatic
10. Precision Optics Corporation, Inc. Announces Operating Results for the First Quarter Ended September 30, 2012
11. TechPrecision Receives Additional Medical Purchase Orders Exceeding $1.5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets ... the U.S.: Consumer Strategies" report to their offering. ... Pain ... approach and treat their physical pain, emphasizing consumer survey analysis, ... pain sufferers and adults who have selected illnesses/conditions strongly associated ...
(Date:3/24/2017)... March 24, 2017 ShangPharma, a ... and cost-effective drug development and discovery services, ... biotechnology industry, announced today the intent for ... will be consolidating the Contract Research Organizations ... Shanghai ChemPartner. These entities include ChemPartner Shanghai, ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... offering. ... is very strong with a total of 97 drug candidates. Pharma giant ... are involved in the development of the IPF therapeutics. The IPF pipeline ... stage, 15 are in Phase II stage, 12 are in Phase I ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... to prep patients for colonoscopy at the HyGIeaCare® Center that is to be ... FL. , The HyGIeaCare® Prep, cleared by the U.S. Food and ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate ... during what is often a very difficult and challenging time.” , A Certified ...
(Date:3/24/2017)... ... ... Time GPS”: a dauntless and enlightened study of the second-coming of Christ, and ... published author, Wesley Gerboth, a World War II veteran, with a highly-regarded reputation as ... ninety-one, he shares the Wisdom God bestowed upon him in this publication. , ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... of inspiring stories about real people of God in congregations across the United ... Miller, a Presbyterian minister ordained in 1964 who has served congregations in seven ...
(Date:3/23/2017)... Greensboro, NC & Seattle, WA (PRWEB) , ... March 23, 2017 ... ... international public health emergency and now estimates that there could be four million Zika-related ... fastest growing epidemics to date with numbers of US cases reported per year skyrocketing ...
Breaking Medicine News(10 mins):